- Home
- PRTA vs THW Comparison
PRTA vs THW Comparison
Compare PRTA & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- THW
- Stock Information
- Founded
- PRTA 2012
- THW 2015
- Country
- PRTA Ireland
- THW United States
- Employees
- PRTA N/A
- THW N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- PRTA Health Care
- THW Finance
- Exchange
- PRTA Nasdaq
- THW Nasdaq
- Market Cap
- PRTA 472.1M
- THW 482.0M
- IPO Year
- PRTA N/A
- THW N/A
- Fundamental
- Price
- PRTA $10.45
- THW $12.06
- Analyst Decision
- PRTA Buy
- THW
- Analyst Count
- PRTA 9
- THW 0
- Target Price
- PRTA $17.71
- THW N/A
- AVG Volume (30 Days)
- PRTA 567.7K
- THW 149.9K
- Earning Date
- PRTA 11-06-2025
- THW 01-01-0001
- Dividend Yield
- PRTA N/A
- THW 10.76%
- EPS Growth
- PRTA N/A
- THW N/A
- EPS
- PRTA N/A
- THW N/A
- Revenue
- PRTA $11,786,000.00
- THW N/A
- Revenue This Year
- PRTA N/A
- THW N/A
- Revenue Next Year
- PRTA $672.02
- THW N/A
- P/E Ratio
- PRTA N/A
- THW N/A
- Revenue Growth
- PRTA N/A
- THW N/A
- 52 Week Low
- PRTA $4.32
- THW $9.76
- 52 Week High
- PRTA $18.65
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- PRTA 56.63
- THW 35.12
- Support Level
- PRTA $10.02
- THW $11.85
- Resistance Level
- PRTA $11.17
- THW $13.13
- Average True Range (ATR)
- PRTA 0.56
- THW 0.24
- MACD
- PRTA -0.07
- THW -0.15
- Stochastic Oscillator
- PRTA 37.37
- THW 16.02
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.